ICON Public (NASDAQ:ICLR) Releases FY 2024 Earnings Guidance

ICON Public (NASDAQ:ICLR) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided EPS guidance of 13.900-14.100 for the period, compared to the consensus EPS estimate of 15.060. The company issued revenue guidance of $8.3 billion-$8.3 billion, compared to the consensus revenue estimate of $8.5 billion. ICON Public also updated its FY24 guidance to $13.90-14.10 EPS.

Analyst Ratings Changes

Several brokerages recently commented on ICLR. Truist Financial dropped their target price on ICON Public from $383.00 to $363.00 and set a “buy” rating on the stock in a report on Monday, October 14th. Evercore ISI dropped their price objective on shares of ICON Public from $360.00 to $350.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Barclays decreased their target price on shares of ICON Public from $350.00 to $330.00 and set an “overweight” rating for the company in a research note on Tuesday, October 15th. Robert W. Baird cut their price objective on shares of ICON Public from $368.00 to $340.00 and set an “outperform” rating on the stock in a report on Friday, September 20th. Finally, Leerink Partnrs raised shares of ICON Public to a “strong-buy” rating in a research report on Wednesday, September 18th. Two equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $346.09.

ICON Public Stock Performance

Shares of ICLR traded down $2.73 during mid-day trading on Wednesday, hitting $280.76. The stock had a trading volume of 1,917,261 shares, compared to its average volume of 584,193. ICON Public has a fifty-two week low of $222.32 and a fifty-two week high of $347.72. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.36. The company has a market cap of $23.16 billion, a PE ratio of 34.49, a PEG ratio of 1.35 and a beta of 1.22. The company’s fifty day simple moving average is $302.52 and its two-hundred day simple moving average is $311.80.

ICON Public (NASDAQ:ICLR) last released its quarterly earnings data on Wednesday, July 24th. The medical research company reported $3.75 EPS for the quarter, topping analysts’ consensus estimates of $3.68 by $0.07. ICON Public had a net margin of 8.57% and a return on equity of 12.06%. The firm had revenue of $2.10 billion during the quarter, compared to the consensus estimate of $2.14 billion. During the same quarter in the previous year, the company posted $2.96 earnings per share. The firm’s revenue was up 4.1% on a year-over-year basis. On average, equities analysts expect that ICON Public will post 14.54 earnings per share for the current year.

ICON Public Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.